Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials (2022)
Attributed to:
Vascular disease meta analyses
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)02074-8
PubMed Identifier: 36351458
Publication URI: http://europepmc.org/abstract/MED/36351458
Type: Journal Article/Review
Parent Publication: The Lancet
Issue: 10365
ISSN: 0140-6736